Breaking News
October 22, 2018 - In Kids with Autism, Short Questionnaire May Detect GI Disorders
October 22, 2018 - Merck presents MK-1454 Phase 1 data for treatment of advanced solid tumors or lymphomas
October 22, 2018 - Aspirin may be effective in preventing blood clots after knee replacement
October 22, 2018 - Gilead Sciences presents Phase 3 results of filgotinib in biologic-experienced rheumatoid arthritis at 2018 ACR/ARHP Annual Meeting
October 22, 2018 - Immunotherapy with pembrolizumab extends survival in metastatic or recurrent head and neck cancer
October 22, 2018 - Health Tip: Keep Ticks Away
October 22, 2018 - Obsessive-compulsive disorder – Genetics Home Reference
October 22, 2018 - Researchers find disrupted functional connectivity in cerebellum of adults with HF-ASD
October 22, 2018 - Deciphera presents Phase 1 clinical results of DCC-2618 in patients with gastrointestinal stromal tumors
October 22, 2018 - Combination of Opdivo and Yervoy shows four-year survival benefits in patients with advanced melanoma
October 22, 2018 - Overcoming bottlenecks in early drug discovery with the power of sound
October 22, 2018 - Scientists discover genes that contribute to ADHD development
October 22, 2018 - Incyte announces Phase 2 FIGHT-202 trial data in patients with cholangiocarcinoma
October 22, 2018 - FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis
October 22, 2018 - At-home biofeedback therapy effective in relieving difficult-to-treat constipation
October 22, 2018 - Merck presents KEYNOTE-057 trial results for patients with high-risk non-muscle invasive bladder cancer
October 22, 2018 - People with periodontal disease less likely to reach healthy blood pressure ranges
October 22, 2018 - Phase III LONSURF study shows progression-free survival in patients with refractory metastatic gastric cancer
October 22, 2018 - Primary care doctors ‘not doing enough’ to curb STDs
October 22, 2018 - Pfizer announces PALOMA-3 trial results in patients with HR+, HER2- metastatic breast cancer
October 22, 2018 - ImmunoGen announces study results of platinum-resistant ovarian cancer therapy at ESMO 2018 Congress
October 22, 2018 - Study findings could set new standard of care for advanced anal cancer
October 22, 2018 - Erlotinib improves progression-free survival in EGFR mutated NSCLC
October 22, 2018 - Pain, insomnia, and depression often drive osteoarthritis patients to seek medical care
October 22, 2018 - The International Society of Refractive Surgery honors Vivior Chairman with Casebeer Award
October 22, 2018 - Multi-strain probiotic helps reduce chemotherapy-induced diarrhea in cancer patients
October 22, 2018 - Study shows potential of avelumab plus axitinib as new treatment option for patients with advanced RCC
October 22, 2018 - Vertex gets European CHMP positive opinion for KALYDECO to treat patients with cystic fibrosis
October 22, 2018 - Phase III trial reports positive results with HDAC inhibitor in advanced breast cancer patients
October 22, 2018 - Prostate radiotherapy improves survival in men with low burden of metastatic disease
October 22, 2018 - Duration of respiratory disturbances may better predict mortality risk from OSA
October 22, 2018 - Free phone app helps low-income obese patients to lose weight
October 22, 2018 - Immunotherapy with nivolumab and ipilimumab may improve survival in patients with MSI-high metastatic colorectal cancers
October 22, 2018 - FOTIVDA expected to be included in new ESMO guidelines for advanced renal cell carcinoma
October 22, 2018 - Compression Collar May Protect Brain of Female Soccer Players
October 22, 2018 - Technique visualizes neuron communication
October 22, 2018 - Advancement in medical imaging methods for health care
October 22, 2018 - Takeda presents vedolizumab phase 3 VISIBLE 1 trial results for treatment of moderately to severely active ulcerative colitis
October 22, 2018 - Immunotherapy increases survival in some patients with metastatic triple negative breast cancer
October 22, 2018 - Exelixis presents CABOSUN and METEOR trial results in patients with advanced renal cell carcinoma
October 22, 2018 - LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer
October 22, 2018 - Brainlab unveils ExacTrac Dynamic at ASTRO meeting in San Antonio, Texas
October 22, 2018 - Not exercising is worse than smoking, diabetes or heart disease finds study
October 22, 2018 - Shorter course of trastuzumab could be an option for women with HER2+ early breast cancer
October 22, 2018 - Map of Mouse Hippocampus Could Be Weapon Against Alzheimer’s
October 22, 2018 - Psychotropic polypharmacy is common in Alzheimer’s disease
October 22, 2018 - Texas A&M and UTA establish Texas Genomics Core Alliance
October 22, 2018 - Analyzing mouse’s potential as animal model of decision-making
October 22, 2018 - Radiotherapy can prolong survival in prostate cancer
October 22, 2018 - A genetic mutation involved in relapse
October 21, 2018 - Report reveals growing impact of cannabis on young people
October 21, 2018 - NSF awards $5 million grant to help scientists magnify societal impact of research
October 21, 2018 - Fertility Rates Down for Each Urbanization Level 2007 to 2017
October 21, 2018 - Genetically engineered 3-D human muscle transplant in a murine model
October 21, 2018 - Moms’ tight work schedules may affect their children’s sleep
October 21, 2018 - AHA: No Direct Link Between Preeclampsia and Cognitive Impairment, Study Finds
October 21, 2018 - Weight loss success linked with active self-control regions of the brain
October 21, 2018 - Scripps researchers successfully test potential new smoking-cessation treatment in rodents
October 21, 2018 - More accurate and less stressful way to measure a baby’s heartbeat
October 21, 2018 - Researchers show better cardiorespiratory fitness leads to longer life
October 21, 2018 - Healthy candies for diabetic patients
October 21, 2018 - Environment impact of microplastics remains unclear
October 21, 2018 - Antibiotics for appendicitis? Surgery often not needed
October 21, 2018 - AHA and AMA recognize more than 800 medical practices, health systems for blood pressure control
October 21, 2018 - Scientists obtain clearest ever image of Ebola virus protein
October 21, 2018 - Study reveals connection between two proteins known to be hyperactive in cancer
October 21, 2018 - Gabapentin Beats Pregabalin for Chronic Sciatica
October 21, 2018 - Cosmetic surgeons offering incomplete information for breast augmentation customers
October 21, 2018 - Chronic sleep disruption in early adult life accelerates AD-related tau pathology
October 21, 2018 - Take 10 for Mindfulness – Drugs.com MedNews
October 21, 2018 - Length of breathing disruption in OSA may be better predictor of mortality risk
October 21, 2018 - ApoE4 gene linked with chronic inflammation increases risk for Alzheimer’s disease
October 21, 2018 - Mother-daughter conflict associated with suicide risk in abused adolescent girls
October 21, 2018 - Scientists molding bacteria into unnatural shapes
October 21, 2018 - High diet quality associated with lower risk of death in colorectal cancer patients
October 21, 2018 - Discharged mental health patients ‘at greater risk of dying’
October 21, 2018 - Research provides insight into neurobiology of aggression and bullying
October 21, 2018 - As billions in tax dollars flow to private Medicaid plans, Who’s minding the store?
October 21, 2018 - Neuroscientists identify brain region that appears to be related to food preference decisions
October 21, 2018 - Deaths related to air pollution in the U.S. decreased by 47% between 1990 and 2010
AFib Tx at Rural Hospitals Tied to Higher Death Risk

AFib Tx at Rural Hospitals Tied to Higher Death Risk

image_pdfDownload PDFimage_print

Action Points

  • Patients hospitalized for atrial fibrillation in rural hospitals were more likely to die than patients admitted to urban hospitals.
  • The study suggests that improvement in atrial fibrillation care in rural hospitals is needed to further reduce the risk of mortality associated with hospital admission for atrial fibrillation.

Patients hospitalized for atrial fibrillation in rural hospitals were more likely to die than patients admitted to urban hospitals, according to a cross-sectional analysis involving close to 250,000 hospitalizations.

Rural hospital admission was associated with a 17% increased risk of death, compared with admission to urban hospitals in the adjusted multivariate model, reported Wesley T. O’Neal, MD, of Emory University School of Medicine in Atlanta, and colleagues.

Multivariate modelling adjusted for potential mortality confounders and propensity score-matched analysis both showed rural hospital mortality to be higher, as did subgroup analyses by sex, race, and region, they wrote in HeartRhythm.

The findings suggest that improvements in atrial fibrillation (AF) care could reduce mortality in rural hospital settings, they added, stating that “Further research is needed to understand the reasons for this finding and suggest that improvement in AF care in rural hospitals is needed to further reduce the risk of mortality associated with hospital admission for AF.”

Hospitalizations for atrial fibrillation have increased dramatically in the U.S. in recent years, with one study showing a 23% increase in a single decade (2000-2010).

The researchers noted that at least half a dozen studies published since 2000 suggest that quality of care, as well as outcomes, for patients hospitalized for cardiovascular causes varies between urban and rural hospitals. They added that mortality differences among patients admitted for atrial fibrillation have not been previously studied.

“Less optimal care of patients with AF has been reported in rural compared to urban areas, which supports the possibility of poorer outcomes in patients with AF admitted to rural hospitals,” they wrote.

In their cross-sectional examination of patients hospitalized for atrial fibrillation, the researchers analyzed data from the National Inpatient Sample for the period 2012 through 2014.

Hospitals were classified as urban or rural based on core-based statistical areas, while in-hospital mortality was defined as death due to any cause during hospitalization.

The mean age of the 248,785 patients included in the analysis was 69; 78% were white; and 48% were women. Also, 88% received treatment at urban hospitals and 12% were treated at rural hospitals.

Among the main findings, a higher percentage of patients admitted for atrial fibrillation died in rural hospitals compared to urban hospitals (1.3% versus 1.0%, P<0.001).

Patients admitted to rural hospitals had an increased risk for death compared with those admitted to urban hospitals in the multivariate model accounting for differences in patient characteristics (OR, 1.17, 95% CI 1.04 to 1.32).

The elevated death risk associated with urban hospital admission persisted after exclusion of patients who had external electrical cardioversion or catheter ablation procedures (OR, 1.14, 95% CI 1.01 to 1.28).

Similar results were seen in a propensity score-matched cohort and in subgroup analyses by sex, race, and region.

Patients admitted to urban hospitals for atrial fibrillation were more likely to have secondary diagnoses of heart failure, hyperlipidemia, and acute kidney injury than those from rural hospitals.

The researchers noted that the risk of in-hospital mortality in patients admitted for atrial fibrillation has actually declined in recent years, due, in part, to the greater use of treatments like external electrical cardioversion and catheter ablation.

They added that while the reasons for the observed rural hospital death increase are unclear, “differences in practice patterns possibly explain this finding.”

Eight percent of the patients in the cohort admitted to urban hospitals received external electrical cardioversion versus 4% of patients treated at rural hospitals (P<0.001), while 9% of patients treated at urban hospitals received catheter ablation, compared with just 1% of patients treated at rural hospitals.

In an accompanying editorial, Thomas Deering, MD, and Ashish Bhimani, MD, of the Piedmont Heart Institute in Atlanta, wrote that while some studies have shown inequities in atrial fibrillation care in rural hospitals, others have shown no significant differences in care compared with non-rural hospitals.

“If the higher rural AF mortality rates noted in the study by O’Neal et al were related primarily to the delivery of AF care, one might expect to see higher cardiovascular and/or stroke-related mortality rates and not just overall higher mortality rates,” they wrote. “Unfortunately, the methodologic design of this study precludes such an analysis. Furthermore, the small absolute mortality difference between rural (1.3%) and urban (1.0%) patients, in which the reasons for those differences remain unknown, makes it difficult to determine the clinical importance of the observed results and suggest effective health policy approaches.”

Study limitations included the inability to distinguish between cases of new-onset and preexisting atrial fibrillation and lack of information on cause of death.

The study was funded by the National Heart, Lung, and Blood Institute.

O’Neal and co-authors, as well as Deering and Bhimani, disclosed no relevant relationships with industry.

  • Reviewed by
    Robert Jasmer, MD Associate Clinical Professor of Medicine, University of California, San Francisco and Dorothy Caputo, MA, BSN, RN, Nurse Planner

2017-12-12T00:00:00-0500

last updated

Tagged with:

About author

Related Articles